Selhorst P, Combrinck C, Ndabambi N, Ismail SD, Abrahams M-R, Lacerda M, Samsunder N, Garrett N, Abdool Karim Q, Abdool Karim SS, Williamson C.
Journal of Virology 2017; 91(8): e01806-16.
Tomita A, Vandormael AM, Bärnighausen T, de Oliveira T, Tanser F.
JAIDS 2017; 75(2): 164-174.
Nonghanphithak D, Reechaipichitkul W, Namwat W, Naranbhai V, Faksri K.
Tuberculosis 2017; 105: 28-34.
Senzani S, Li D, Bhaskar A, Ealand C, Chang J, Rimal B, Liu C, Joon Kim S, Dhar N, Kana B.
Scientific Reports 2017; 7(1):1140.
Padayatchi N, Mahomed S, O’Donnell M, Conradie F, Naidoo K.
South African Medical Journal 2017; 107(6):466.
Happel AU, Jaumdally SZ, Pidwell T, Cornelius T, Jaspan HB, Froissart R, Barnabas SL,Passmore Jo-AS.
BMC Women's Health 2017; 17(1):7.
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.